987 related articles for article (PubMed ID: 19458556)
21. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
[TBL] [Abstract][Full Text] [Related]
25. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
[TBL] [Abstract][Full Text] [Related]
26. T1/T2 non-small-cell lung cancer treated by lobectomy: does tumor anatomic location matter?
Whitson BA; Groth SS; Andrade RS; Habermann EB; Maddaus MA; D'Cunha J
J Surg Res; 2012 Oct; 177(2):185-90. PubMed ID: 22921916
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004.
Inoue M; Okumura M; Sawabata N; Miyaoka E; Asamura H; Yoshino I; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Kobayashi H; Yokoi K
Lung Cancer; 2014 Feb; 83(2):246-51. PubMed ID: 24296124
[TBL] [Abstract][Full Text] [Related]
28. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.
Lyons G; Quadrelli S; Silva C; Vera K; Iotti A; Venditti J; Chertcoff J; Chimondeguy D
J Thorac Oncol; 2008 Sep; 3(9):989-93. PubMed ID: 18758301
[TBL] [Abstract][Full Text] [Related]
29. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
Port JL; Korst RJ; Lee PC; Kansler AL; Kerem Y; Altorki NK
Ann Thorac Surg; 2007 Feb; 83(2):397-400. PubMed ID: 17257959
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
31. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
33. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
Shepherd FA; Crowley J; Van Houtte P; Postmus PE; Carney D; Chansky K; Shaikh Z; Goldstraw P;
J Thorac Oncol; 2007 Dec; 2(12):1067-77. PubMed ID: 18090577
[TBL] [Abstract][Full Text] [Related]
34. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
35. Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
Yoshino I; Yoshida S; Miyaoka E; Asamura H; Nomori H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
J Thorac Oncol; 2012 May; 7(5):850-5. PubMed ID: 22481238
[TBL] [Abstract][Full Text] [Related]
36. A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.
Blaauwgeers H; Damhuis R; Lissenberg-Witte BI; de Langen AJ; Senan S; Thunnissen E
J Thorac Oncol; 2019 Mar; 14(3):459-467. PubMed ID: 30408568
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
38. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
40. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
